annual EBITDA:
-$390.12M+$43.18M(+9.97%)Summary
- As of today (June 4, 2025), GH annual EBITDA is -$390.12 million, with the most recent change of +$43.18 million (+9.97%) on December 31, 2024.
- During the last 3 years, GH annual EBITDA has fallen by -$30.50 million (-8.48%).
- GH annual EBITDA is now -889.60% below its all-time high of -$39.42 million, reached on December 31, 2016.
Performance
GH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$83.84M+$15.35M(+15.47%)Summary
- As of today (June 4, 2025), GH quarterly EBITDA is -$83.84 million, with the most recent change of +$15.35 million (+15.47%) on March 31, 2025.
- Over the past year, GH quarterly EBITDA has increased by +$19.38 million (+18.78%).
- GH quarterly EBITDA is now -860.17% below its all-time high of -$8.73 million, reached on June 30, 2019.
Performance
GH quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$370.74M+$19.38M(+4.97%)Summary
- As of today (June 4, 2025), GH TTM EBITDA is -$370.74 million, with the most recent change of +$19.38 million (+4.97%) on March 31, 2025.
- Over the past year, GH TTM EBITDA has increased by +$43.48 million (+10.50%).
- GH TTM EBITDA is now -1275.76% below its all-time high of -$26.95 million, reached on September 30, 2017.
Performance
GH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GH EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.0% | +18.8% | +10.5% |
| 3 y3 years | -8.5% | +27.4% | +0.7% |
| 5 y5 years | -582.9% | -194.2% | -447.2% |
GH EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -8.5% | +36.6% | -37.5% | +61.8% | at high | +40.4% |
| 5 y | 5-year | -582.9% | +36.6% | -194.2% | +61.8% | -447.2% | +40.4% |
| alltime | all time | -889.6% | +36.6% | -860.2% | +61.8% | -1275.8% | +40.4% |
GH EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$83.84M(-15.5%) | -$370.74M(-5.0%) |
| Dec 2024 | -$390.12M(-10.0%) | -$99.19M(+2.8%) | -$390.12M(-16.5%) |
| Sep 2024 | - | -$96.48M(+5.8%) | -$467.00M(+5.1%) |
| Jun 2024 | - | -$91.23M(-11.6%) | -$444.45M(+7.3%) |
| Mar 2024 | - | -$103.22M(-41.4%) | -$414.22M(-4.4%) |
| Dec 2023 | -$433.31M(-29.5%) | -$176.07M(+138.2%) | -$433.31M(+12.3%) |
| Sep 2023 | - | -$73.93M(+21.2%) | -$385.75M(-16.7%) |
| Jun 2023 | - | -$61.00M(-50.1%) | -$463.25M(-25.5%) |
| Mar 2023 | - | -$122.30M(-4.8%) | -$621.81M(+1.1%) |
| Dec 2022 | -$614.91M(+71.0%) | -$128.52M(-15.1%) | -$614.91M(+11.4%) |
| Sep 2022 | - | -$151.43M(-31.0%) | -$551.96M(+10.0%) |
| Jun 2022 | - | -$219.56M(+90.2%) | -$501.77M(+34.4%) |
| Mar 2022 | - | -$115.41M(+76.0%) | -$373.44M(+3.8%) |
| Dec 2021 | -$359.62M | -$65.57M(-35.2%) | -$359.62M(-4.7%) |
| Sep 2021 | - | -$101.24M(+11.0%) | -$377.50M(+9.9%) |
| Jun 2021 | - | -$91.22M(-10.2%) | -$343.50M(+15.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$101.59M(+21.8%) | -$298.17M(+32.5%) |
| Dec 2020 | -$225.07M(+294.0%) | -$83.44M(+24.1%) | -$225.07M(+40.3%) |
| Sep 2020 | - | -$67.24M(+46.5%) | -$160.46M(+52.9%) |
| Jun 2020 | - | -$45.89M(+61.0%) | -$104.91M(+54.8%) |
| Mar 2020 | - | -$28.50M(+51.3%) | -$67.75M(+18.6%) |
| Dec 2019 | -$57.13M(-24.7%) | -$18.83M(+61.0%) | -$57.13M(-6.4%) |
| Sep 2019 | - | -$11.69M(+33.9%) | -$61.07M(-13.5%) |
| Jun 2019 | - | -$8.73M(-51.2%) | -$70.58M(-13.5%) |
| Mar 2019 | - | -$17.88M(-21.5%) | -$81.60M(+7.6%) |
| Dec 2018 | -$75.84M(+0.7%) | -$22.77M(+7.4%) | -$75.84M(+14.2%) |
| Sep 2018 | - | -$21.20M(+7.3%) | -$66.43M(-8.0%) |
| Jun 2018 | - | -$19.75M(+63.0%) | -$72.17M(+37.7%) |
| Mar 2018 | - | -$12.12M(-9.3%) | -$52.42M(+30.1%) |
| Dec 2017 | -$75.31M(+91.0%) | -$13.36M(-50.4%) | -$40.30M(+49.6%) |
| Sep 2017 | - | -$26.95M | -$26.95M |
| Dec 2016 | -$39.42M | - | - |
FAQ
- What is Guardant Health annual EBITDA?
- What is the all time high annual EBITDA for Guardant Health?
- What is Guardant Health annual EBITDA year-on-year change?
- What is Guardant Health quarterly EBITDA?
- What is the all time high quarterly EBITDA for Guardant Health?
- What is Guardant Health quarterly EBITDA year-on-year change?
- What is Guardant Health TTM EBITDA?
- What is the all time high TTM EBITDA for Guardant Health?
- What is Guardant Health TTM EBITDA year-on-year change?
What is Guardant Health annual EBITDA?
The current annual EBITDA of GH is -$390.12M
What is the all time high annual EBITDA for Guardant Health?
Guardant Health all-time high annual EBITDA is -$39.42M
What is Guardant Health annual EBITDA year-on-year change?
Over the past year, GH annual EBITDA has changed by +$43.18M (+9.97%)
What is Guardant Health quarterly EBITDA?
The current quarterly EBITDA of GH is -$83.84M
What is the all time high quarterly EBITDA for Guardant Health?
Guardant Health all-time high quarterly EBITDA is -$8.73M
What is Guardant Health quarterly EBITDA year-on-year change?
Over the past year, GH quarterly EBITDA has changed by +$19.38M (+18.78%)
What is Guardant Health TTM EBITDA?
The current TTM EBITDA of GH is -$370.74M
What is the all time high TTM EBITDA for Guardant Health?
Guardant Health all-time high TTM EBITDA is -$26.95M
What is Guardant Health TTM EBITDA year-on-year change?
Over the past year, GH TTM EBITDA has changed by +$43.48M (+10.50%)